Viread Lawsuit

The pharmaceutical company Gilead Sciences is currently facing legal allegations that the corporation shelved a less toxic HIV medication while it continued to reap profits from Viread, a TDF (tenofovir disoproxil fumarate) drug, tied to serious kidney problems and bone damage. Viread users who have filed lawsuits against the drug’s manufacturer allege that these side effects were not sufficiently explained, and even downplayed, in the drug’s marketing and product labeling.

HIV Litigation Attorneys™ believes that Gilead deliberately suppressed the development and availability of a safer antiretroviral in order to exploit the full patent life of existing TDF drugs like Viread. Litigation is in its early stages. Now is the time to join forces with the law firm that is leading the charge against Gilead.

If you or a family member took Viread and experienced either bone loss or kidney problems, please call our firm for a free legal evaluation. Our team brings a unique level of expertise to the emerging TDF HIV litigation as it relates to these serious side effects, and we promise you our full commitment to fighting your legal battle.

Read on to learn more about the some of the risks allegedly linked to long-term treatment with tenofovir disoproxil fumarate, and whether you may be eligible to file a Viread lawsuit.

About Viread

Viread, an antiretroviral manufactured by Gilead Sciences, was FDA-approved for the treatment of HIV in conjunction with other antiretroviral agents. It is also approved to treat chronic hepatitis B in adults and children over the age of 12. Viread belongs to a class of anti-HIV medicines called nucleoside reverse transcriptase inhibitors (NRTIs). This class of HIV drugs prevent the virus from replicating and is purported to help HIV positive patients live longer and healthier lives.

Failure to Warn of Viread Side Effects

In legal actions pending against Gilead, plaintiffs are seeking damages for kidney and bone injuries that left them with serious financial, physical and emotional hardships. They allege that long-term exposure to Viread and other HIV drugs containing TDF has caused side effects including:

  • Bone demineralization
  • Loss of bone density (osteopenia)
  • Bone fractures
  • Osteoporosis
  • Kidney damage or declining function
  • Renal failure
  • Chronic kidney disease

Viread Lawsuit Allegations

If you believed that Viread was safe for the long-term treatment of HIV based on Gilead’s promotion and marketing, you’re in good company. Growing litigation suggests that this drug maker prioritized its profits over consumer safety.

Many plaintiffs who suffered bone and kidney injuries after taking Viread claim they would have avoided the drug altogether had they been presented with a comprehensive list of side effects. The FDA even admonished Gilead for making false or misleading statements about the safety and benefits of TDF.

HIV Litigation Attorneys™ believes that Gilead Sciences purposefully overstated Viread’s drug effectiveness while concealing potential side effects to maximize profits on Viread and other TDF drugs until their patent expired, exposing patients to very serious health risks. When Big Pharma takes such unscrupulous measures, they should be held responsible.

Zealous advocacy for HIV Drug Injuries

HIV Litigation Attorneys™ is actively investigating potential legal claims by those who have suffered bone loss and kidney problems after long-term treatment with Viread and other TDF HIV drugs. We operate on a contingency basis, meaning there are no costs for legal representation unless a settlement or jury verdict is obtained in your favor.

Don’t delay in arranging a free consultation to discuss your case and options for legal recovery. There are specific time limits for taking legal action, which vary by state. Find out if you have a valid Viread claim today.

Additional Resources:

  1. Business Wire, California HIV Patients File Class Action and Personal Injury Cases Over Key HIV Drug https://www.businesswire.com/news/home/20180509005703/en/Gilead-Lawsuits-California-HIV-Patients-File-Class
  2. US Department of Health and Human Services, Viread (generic: tenofovir disoproxil fumarate) https://aidsinfo.nih.gov/drugs/290/tenofovir-disoproxil-fumarate/0/patient
  3. RX List, Viread Side Effects https://www.rxlist.com/viread-side-effects-drug-center.htm
  4. South Africa Journal of HIV Medicine, An overview of tenofovir and renal disease for the HIV-treating clinician https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111387/
  5. BMJ Journal, Renal and bone safety of tenofovir alafenamide vs tenofovir disoproxil fumarate https://sti.bmj.com/content/91/Suppl_1/A48.3